Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.9B | 2.3B | 1.9B | 1.9B |
Cost of revenue | 1.8B | 1.3B | 973M | 911M |
Gross profit | 1.2B | 976M | 883M | 994M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 649M | 483M | 424M | 467M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 238M | 222M | 195M | 217M |
Other income expense | -33M | 19M | 16M | 11M |
Pretax income | 378M | 280M | 245M | 261M |
Tax provision | 81M | 32M | 52M | 33M |
Net income | 297M | 248M | 193M | 228M |
Basic EPS | 0.5 | — | 0.3 | 0.4 |
Diluted EPS | 0.5 | — | 0.3 | 0.4 |
Basic average shares | 652.2M | — | 648M | 641M |
Diluted average shares | 653.3M | — | 648M | 642M |
EBITDA | 1.0B | 856M | 773M | 863M |
Net income from continuing op. | 297M | 248M | 193M | 228M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |